Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.10.19.760310

Optogenetic and sonogenetic pacing of unmodified cardiac tissue upon quick integration with specialized biological actuators

Pettebone, M. E.·Han, J. L.·Forouzandehmehr, A.·Chesla, O.·Chua, C. J.·Pozo, M. R.·Heinson, Y. W.·Liu, W.·Entcheva, E.
View original source ↗Export metadata ↓

Abstract

Electrical stimulation for cardiac pacing has been in clinical use for 100 years and it is the current standard. Alternative scalable pacing methods that are contactless, with good spatial precision and can also be cell-selective are of interest for both in vitro and in vivo applications. Cardiac pacing by light or by ultrasound (US) can be achieved using optogenetic transduction of the tissue and by enhancing responsiveness to ultrasound. In this work we create specialized biological actuators (cell spheroids) out of generic human cells, modified optogenetically (using Channelrhodopsin2) and sonogenetically (using human Piezo1), guide them to a desired location to promote quick integration with unmodified cardiac syncytia within less than two hours. We quantify their ability to confer pacing by light or US and to entrain the native cardiac tissue, modeled here with human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) grown in monolayers, quasi-3D oriented microtissues or cell spheroids. Magnetic guidance (via magnetic nanoparticles) speeds up integration and facilitates positioning to optimize electrotonic load for pacing; size match and three-dimensional growth also accelerate integration. Computational modeling corroborates the possibility to pace by light and by US. Using optogenetically-gated US pulses (0.5 MHz), we show entrainment in voltage and calcium responses and identify the best performing configurations. Experiments reveal the potential role of Piezo1, esp. when activated with Yoda1. The approach is shown to work with physiologically relevant heart cells, such as human cardiac fibroblasts as optimized actuators, and therefore can be considered for in vivo applications as part of heart regeneration efforts. High-throughput cardiotoxicity testing and drug screening in vitro can directly benefit from deployment of such biological actuators.

Explore related subjects

bioengineeringPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pettebone, M. E., Han, J. L., Forouzandehmehr, A., Chesla, O., Chua, C. J., Pozo, M. R., Heinson, Y. W., Liu, W., Entcheva, E.. 2026-10-20. Optogenetic and sonogenetic pacing of unmodified cardiac tissue upon quick integration with specialized biological actuators. https://doi.org/10.64898/2026.10.19.760310

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Mesoscale Soft Robotics for Mechanically Perturbing and Functionally Monitoring Responses in Human Organoids

Human organoids represent promising models for studies of significance to the biology and medical communities. Of the existing approaches for monitoring organoids, none offers the ability to apply programmable mechanical forces while simultaneously recording multi-modal physiological responses, of relevance to phenomena spanning from traumatic brain injuries to cardiac rhythm disorders. Here, we present a mesoscale soft robotic organoid interface that enables programmable delivery of forces to organoids of diverse shapes, and to map electrophysiological activity and mechanical responses. The platform combines actuation elements with integrated sensors for quantitative measurement and control. Studies using this technology reveal that spheroidal cortical organoids exhibit distinct responses to mechanical trauma, including silencing, recovery, and changes in neuronal firing patterns. Additional experiments on cardiac ring tissues demonstrate that sustained stretching induces beat-to-beat rhythm variability and altered conduction. The results establish a framework for investigating force-triggered transitions between physiological and disease-like states in human tissue models.

bioengineering↗
bioRxiv2026

Few-shot regulatory sequence design with a genomic language model

A central challenge in generative biology is translating knowledge learned from natural sequences and experiments into designs with desired functions. In-context learning (ICL) is an emergent capability of large language models that allows them to adapt to new tasks from a few examples without additional training, enabling these models to become general-purpose learners. Here, we show that the genome language model, Evo 2, exhibits generative ICL in biological sequence design. Prompting with just tens of examples conditions Evo 2 to generate novel and diverse regulatory DNA sequences without any additional training. Mechanistic analysis suggests that genomic ICL may originate from induction, similar to phenomena observed in natural language. Reinforcement learning leveraging sequence-to-function models as experiment-derived rewards further strengthens ICL. We first validate this approach by generating enhancers that drive cell-type-specific gene expression in three human cell lines. Extending this approach in vivo, enhancers designed using human regulatory element data selectively label layer 5 extratelencephalic neurons in the mouse cortex with high specificity and stronger activity than existing enhancers. Our study provides evidence of emergent properties in genomic sequence models and introduces a promising approach for improving functional conditioning in generative biology.

bioengineering↗
bioRxiv2026

IOP-independent treatment for neurodegeneration in glaucoma using optimized ROS-scavenging microparticles for sustained release of erythropoietin

Glaucoma is a slow-progressing neurodegenerative disease of the optic projection to the brain and a leading cause of blindness worldwide. Current treatments are targeted towards lowering intraocular pressure (IOP), the only known, modifiable risk factor; however, this strategy is ineffective in many patients. An early hallmark of glaucomatous neurodegeneration is increased reactive oxygen species (ROS), representing an alternative opportunity for intervention to halt or slow disease progression. In this work, we optimize a ROS-scavenging copolymer, poly(propylene sulfide-co-ethylene sulfide) (PPSES), for formulation of size-controlled, stabilized, antioxidant microparticles (MPs) for sustained release of the protein erythropoietin (EPO). EPO promotes biological antioxidant defense via activation of NRF2-mediated transcription of antioxidant genes. This MP system overcomes the short half-life of EPO and leverages the combined benefits of bioactive EPO with long-lasting, inherently antioxidant PPSES MPs. The lead EPO-MP formulation preserves neurons in both mouse and non-human primate models of glaucoma through suppression of oxidative stress and optic nerve degeneration. EPO-loaded PPSES MPs represent a translationally relevant therapy for long-term management of glaucoma independent of IOP.

bioengineering↗